University of Sherbrooke defensive lineman Mickael Badra has tested positive for a banned substance.
The Canadian Centre for Ethics in Sport took a urine sample that was collected during in-competition doping control on October 19, 2019. It revealed the presence of D-amphetamine, a prohibited stimulant. Badra has received a sanction of four years for an anti-doping rule violation.
In response to the CCES’s assertion, Badra requested a hearing to contest both the violation and proposed sanction. According to the CCES, Badra failed to participate in the hearing process, although the hearing proceeded by way of a documentary review.
In his decision, arbitrator Ross Dumoulin confirmed the asserted violation and imposed a sanction of four years ineligibility from sport, which concludes on January 29, 2024. During the sanction period, the athlete, who resides in Sherbrooke is ineligible to participate in any capacity with any sport signatory to the Canadian Anti-Doping Program, including training with teammates.
The CCES is an independent, national, not-for profit organization with a responsibility to administer the CADP. Under the CADP rules, the CCES announces publicly every anti-doping rule violation.
CCES recognizes that true sport can make a great difference for individuals, communities and country. The organization is committed to making sport better by working collaboratively to activate a values-based and principle-driven sport system; protecting the integrity of sport from the negative forces of doping and other unethical threats; and advocating for sport that is fair, safe and open to everyone.